107 related articles for article (PubMed ID: 20953137)
21. HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
Fok JHL; Hedayat S; Zhang L; Aronson LI; Mirabella F; Pawlyn C; Bright MD; Wardell CP; Keats JJ; De Billy E; Rye CS; Chessum NEA; Jones K; Morgan GJ; Eccles SA; Workman P; Davies FE
Clin Cancer Res; 2018 May; 24(10):2395-2407. PubMed ID: 29391353
[No Abstract] [Full Text] [Related]
22. Sample-based modeling reveals bidirectional interplay between cell cycle progression and extrinsic apoptosis.
Imig D; Pollak N; Allgöwer F; Rehm M
PLoS Comput Biol; 2020 Jun; 16(6):e1007812. PubMed ID: 32497127
[TBL] [Abstract][Full Text] [Related]
23. p53 regulates CD46 expression and measles virus infection in myeloma cells.
Lok A; Descamps G; Tessoulin B; Chiron D; Eveillard M; Godon C; Le Bris Y; Vabret A; Bellanger C; Maillet L; Barillé-Nion S; Gregoire M; Fonteneau JF; Le Gouill S; Moreau P; Tangy F; Amiot M; Moreau-Aubry A; Pellat-Deceunynck C
Blood Adv; 2018 Dec; 2(23):3492-3505. PubMed ID: 30530776
[TBL] [Abstract][Full Text] [Related]
24. Synergistic Effects of Arsenic Trioxide and Radiation: Triggering the Intrinsic Pathway of Apoptosis.
Moloudi K; Neshasteriz A; Hosseini A; Eyvazzadeh N; Shomali M; Eynali S; Mirzaei E; Azarnezhad A
Iran Biomed J; 2017 Sep; 21(5):330-7. PubMed ID: 28459147
[TBL] [Abstract][Full Text] [Related]
25. Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer.
Rajaram S; Synnott NC; Crown J; Madden SF; Duffy MJ
Transl Oncol; 2024 Aug; 46():102025. PubMed ID: 38870678
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of toxic effects induced by arsenic trioxide or/and antimony on autophagy and apoptosis in testis of adult mice.
Wu S; Zhong G; Wan F; Jiang X; Tang Z; Hu T; Rao G; Lan J; Hussain R; Tang L; Zhang H; Huang R; Hu L
Environ Sci Pollut Res Int; 2021 Oct; 28(39):54647-54660. PubMed ID: 34014480
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of arsenic trioxide-mediated changes in human induced pluripotent stem cells (IPS).
Graham B; Stevens J; Wells P; Sims J; Rogers C; Leggett SS; Ekunwe S; Ndebele K
Int J Environ Res Public Health; 2014 Jul; 11(7):7524-36. PubMed ID: 25054231
[TBL] [Abstract][Full Text] [Related]
28. SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma.
Xiao P; Wang J; Li T; Yang A; Qiu D; Chen J; Zeng Z
Mol Carcinog; 2024 Apr; 63(4):728-741. PubMed ID: 38258917
[TBL] [Abstract][Full Text] [Related]
29. DEPDC1B enhances malignant phenotypes of multiple myeloma through upregulating CCNB1 and inhibiting p53 signaling pathway.
Fei H; Shi X; Li S; Li Y; Yin X; Wu Z; Wang W; Shi H; Li R
Tissue Cell; 2024 Feb; 86():102263. PubMed ID: 37979396
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway.
Yang L; Ma L; Gong Q; Chen J; Huang Q
Mol Biol Rep; 2023 Sep; 50(9):7457-7469. PubMed ID: 37477799
[TBL] [Abstract][Full Text] [Related]
31. Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells
Kouhpaikar H; Sadeghian MH; Rafatpanah H; Kazemi M; Iranshahi M; Delbari Z; Khodadadi F; Ayatollahi H; Rassouli FB
Iran J Basic Med Sci; 2020 May; 23(5):616-622. PubMed ID: 32742599
[TBL] [Abstract][Full Text] [Related]
32. N-acetylcysteine alleviates arsenic trioxide-induced reductions in hepatic catalase gene expression both in vitro and in vivo.
Nagano S; Unuma K; Aki T; Uemura K
Leg Med (Tokyo); 2024 May; 69():102458. PubMed ID: 38781725
[TBL] [Abstract][Full Text] [Related]
33. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth.
An R; Liu J; He J; Wang F; Zhang Q; Yu Q
Am J Cancer Res; 2019; 9(9):1905-1921. PubMed ID: 31598394
[TBL] [Abstract][Full Text] [Related]
34. Correction: Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway.
Makowska A; Wahab L; Braunschweig T; Kapetanakis NI; Vokuhl C; Denecke B; Shen L; Busson P; Kontny U
Oncotarget; 2023 Aug; 14():782-787. PubMed ID: 37646784
[No Abstract] [Full Text] [Related]
35. Inheritance of paternal lifestyles and exposures through sperm DNA methylation.
Greeson KW; Crow KMS; Edenfield RC; Easley CA
Nat Rev Urol; 2023 Jun; 20(6):356-370. PubMed ID: 36653672
[TBL] [Abstract][Full Text] [Related]
36. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
Cholujova D; Bujnakova Z; Dutkova E; Hideshima T; Groen RW; Mitsiades CS; Richardson PG; Dorfman DM; Balaz P; Anderson KC; Jakubikova J
Br J Haematol; 2017 Dec; 179(5):756-771. PubMed ID: 29048129
[TBL] [Abstract][Full Text] [Related]
37. Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells.
Stevens JJ; Graham B; Dugo E; Berhaneselassie-Sumner B; Ndebele K; Tchounwou PB
J Cancer Sci Ther; 2017 Jan; 9(1):298-306. PubMed ID: 28966729
[TBL] [Abstract][Full Text] [Related]
38. Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
Cancer Cell Int; 2015; 15():116. PubMed ID: 26692822
[TBL] [Abstract][Full Text] [Related]
39. The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma.
Li X; Sun WJ
Onco Targets Ther; 2015; 8():775-81. PubMed ID: 25914547
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
